SA
GLAXF logo
GSK plc(GLAXF)
Last print unknown agoAbout this dataData status
$23.40▼-1.05 (-4.29%)Stale · unknown old

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 30.8 · very high volatility

Overview →

GSK plc (GLAXF)

R&D Expense Growth

17.28%

Fiscal year · Period ending:

GLAXF logo

GLAXF R&D Expense Growth

Latest reported17.28%
GLAXF FY R&D Growth (YoY) (0.00% → 17.28%)
High-resolution chart · PNG

What is r&d expense growth?

Year-over-year research & development expense growth.

GLAXF r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

GSK plc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
17.2752%
2.8604%
13.3929%
3.9788%
10.1189%
4.9256%
17.3388%
-13.025%
23.3738%
1.9101%
3.1884%
-12.0571%
11.1681%
-4.4572%
-15.1742%
9.1206%
34.8478%
-9.1697%
-7.4779%
12.2819%
7.989%
4.0487%
-3.7586%
13.2413%
1.3818%
99.0544%
9.1144%
1.3066%
-1.1197%
-24.6104%
79.4872%
16.1028%
24.2017%
25.2632%
13.0952%
30.031%
40.4348%
54.3624%
31.8584%
0%

Frequently asked questions: GLAXF r&d expense growth

What is GSK plc (GLAXF)'s current r&d expense growth?

GSK plc (GLAXF)'s latest reported r&d expense growth (Fiscal year) is 17.28% as of Dec 31, 2025. Year-over-year research & development expense growth.

How much historical r&d expense growth data is available for GLAXF?

Stock Alarm Pro provides 40 dated annual fiscal periods observations for GSK plc (GLAXF)'s r&d expense growth, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare GLAXF's r&d expense growth to peers or set an alert?

You can open GLAXF's r&d expense growth in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on GLAXF delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.